Form D · Pharmaceuticals
Gateway Pharmaceuticals, LLC
Trussville, AL · CIK 0001632245
Offering snapshot reported Jan 30, 2015 · SEC filing
- Reported sold
- $16.9K Offering amount: $250K
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $500 Reported outside-investor minimum
- First sale
- Jan 16, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 30, 2015 | Initial | $16,875 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-233185
Source: Form D, filed Jan 30, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bradley Cox | Director |
| Barnett Cox | Director |
| Richard Doughty | Director |
| Mark Mosier, M.D. | Director |
| Trent Richmond | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3532 Vann Rd
Trussville, AL, 35235
Trussville, AL, 35235